Exosome-mediated delivery of CRISPR/Cas9 for targeting of oncogenic KrasG12D in pancreatic cancer.
Life Sci Alliance. 2021 Jul 19;4(9):e202000875. doi: 10.26508/lsa.202000875. Print 2021 Sep.
Life Sci Alliance. 2021.
PMID: 34282051
Free PMC article.